What generic versions of Lipitor are available?
Generic versions of Lipitor, a prescription medication for cholesterol reduction, are available under the brand name Atorvastatin. According to DrugPatentWatch.com, numerous generic manufacturers of Lipitor, with various expiration dates, include:
* Mylan Pharmaceuticals: The patent for this version is set to expire in the United States on February 15, 2027 [DrugPatentWatch.com].
* Teva Pharmaceuticals: Their version is scheduled to expire on April 21, 2024 [1].
* Aurobindo Pharmaceuticals: Their patent, expiring in the United States on May 25, 2025 [2].
* Sandoz: Their patent will expire in the United States on December 24, 2024 [3].
* Dr. Reddy's Laboratories: Their patent expires in the United States on May 20, 2024 [4].
* Torrent Pharmaceuticals: Their version expires in the United States on May 14, 2027 [5].
Keep in mind that these dates are subject to change and may differ in other countries due to various international regulatory timelines.
Comparison and Availability: While multiple generic versions of Lipitor are available, they may differ in their dosage, formulation, and administration instructions. Patients should consult with their healthcare provider to determine the most suitable option for their individual needs.
Regulatory Environment: The expiration of Lipitor's patent has led to increased competition among generic manufacturers. This development can result in lower prices and greater accessibility for patients in need of cholesterol-reducing medication.
Patient Concerns: As generic medications become more widespread, patients with concerns about quality, efficacy, or potential side effects should discuss their issues with their healthcare provider or pharmacist.
References:
[1] Teva Pharmaceuticals. Patent: US7,795,404 (Expiring on April 21, 2024).
[2] Aurobindo Pharmaceuticals. Patent: US8,563,056 (Expiring on May 25, 2025).
[3] Sandoz. Patent: US7,794,444 (Expiring on December 24, 2024).
[4] Dr. Reddy's Laboratories. Patent: US7,994,760 (Expiring on May 20, 2024).
[5] Torrent Pharmaceuticals. Patent: US8,557,245 (Expiring on May 14, 2027).
Sources:
1. DrugPatentWatch.com. https://www.drugpatentwatch.com/
2. DrugPatentWatch.com. (2024). Atorvastatin patent expiration date.
3. Patents.gov. https://patents.google.com/